Skip to content

Clinical trials

Phase 3 Prostatic Neoplasms trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Neoplasms Phase: Phase 3 Country / region: Netherlands Clear all

91 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20013
20033
20041
20053
20062
20074
20084
200911
20106
20114
20122
20133
20145
20151
20171
20183
20194
20207
20215
20225
20231
20244
20254
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed52
Active, not recruiting19
Recruiting8
Terminated8
Unknown status3
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca8
Pfizer7
Ferring Pharmaceuticals6
Janssen Research & Development, LLC4
Merck Sharp & Dohme LLC4
Sanofi4
Aragon Pharmaceuticals, Inc.3
European Organisation for Research and Treatment of Cancer - EORTC3
ABX advanced biochemical compounds GmbH2
Abbott2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Neoplasms91
Neoplasm Metastasis10
Neoplasms7
Disease3
Erectile Dysfunction2
Urogenital Neoplasms2
Carcinoma1
Carcinoma, Non-Small-Cell Lung1
Genital Diseases, Male1
Genital Neoplasms, Male1

Trials

Showing 1 to 25 of 91. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.